BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 32685259)

  • 1. Risk of COVID-19 in oncohematological patients.
    Alcaraz R; Saiz-Rodríguez M; Cuevas B; González-López TJ; Labrador J
    Am J Blood Res; 2020; 10(3):52-53. PubMed ID: 32685259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consensus on COVID-19 Vaccination in Pediatric Oncohematological Patients, on Behalf of Infectious Working Group of Italian Association of Pediatric Hematology Oncology.
    Cesaro S; Muggeo P; Zama D; Cellini M; Perruccio K; Colombini A; Carraro F; Petris MG; Petroni V; Mascarin M; Baccelli F; Soncini E; Mura R; La Spina M; Decembrino N; Burnelli R; Frenos S; Castagnola E; Faraci M; Meazza C; Barzaghi F; D'Amico MR; Capasso M; Calore E; Ziino O; Barone A; Compagno F; Luti L; Galaverna F; De Santis R; Brescia L; Meneghello L; Petrone A; Giurici N; Onofrillo D; Schumacher F; Mercolini F
    J Clin Med; 2022 Feb; 11(5):. PubMed ID: 35268326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncology during the COVID-19 pandemic: challenges, dilemmas and the psychosocial impact on cancer patients.
    Tsamakis K; Gavriatopoulou M; Schizas D; Stravodimou A; Mougkou A; Tsiptsios D; Sioulas V; Spartalis E; Sioulas AD; Tsamakis C; Charalampakis N; Mueller C; Arya D; Zarogoulidis P; Spandidos DA; Dimopoulos MA; Papageorgiou C; Rizos E
    Oncol Lett; 2020 Jul; 20(1):441-447. PubMed ID: 32565968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronavirus disease 2019 (COVID-19): latest developments in potential treatments.
    Hon KL; Leung KKY; Leung AK; Qian SY; Chan VP; Ip P; Wong IC
    Drugs Context; 2020; 9():. PubMed ID: 32655654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the exposure risk of SARS-CoV-2 in different hospital environment.
    Ge XY; Pu Y; Liao CH; Huang WF; Zeng Q; Zhou H; Yi B; Wang AM; Dou QY; Zhou PC; Chen HL; Liu HX; Xu DM; Chen X; Huang X
    Sustain Cities Soc; 2020 Oct; 61():102413. PubMed ID: 32834932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of cervical cancer patients during the COVID-19 pandemic: a challenge for developing countries.
    Del Pilar Estevez-Diz M; Bonadio RC; Miranda VC; Carvalho JP
    Ecancermedicalscience; 2020; 14():1060. PubMed ID: 32582375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 pandemic and patients with cancer: The protocol of a Clinical Oncology center in Tehran, Iran.
    Rakhsha A; Azghandi S; Taghizadeh-Hesary F
    Rep Pract Oncol Radiother; 2020; 25(5):765-767. PubMed ID: 32765192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of COVID-19 on oncology practice and research in the United States.
    Sina-Odunsi AJ
    Public Health Pract (Oxf); 2021 Nov; 2():100191. PubMed ID: 34608461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [COVID-19 in pediatric cancer patients: risk of infection, surveillance and containment].
    Mejía-Aranguré JM; Ocampo-Aguilar AP; Edid-Jaris G
    Rev Med Inst Mex Seguro Soc; 2020 Sep; 58(Supl 2):S282-284. PubMed ID: 34695340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Virus, New Challenge.
    Shi Y
    Innovation (Camb); 2020 May; 1(1):100005. PubMed ID: 33554185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Response of the UK Clinical Oncology Community to the COVID-19 Pandemic.
    Lewis PJ; Roques TW
    Clin Oncol (R Coll Radiol); 2020 Aug; 32(8):493-496. PubMed ID: 32444255
    [No Abstract]   [Full Text] [Related]  

  • 12. Hematology Oncology Patients' Care in a Pandemic Situation of COVID-19: Where Do We Stand?
    Ali K; Wajdi M; Al-Quteimat O
    Hosp Pharm; 2021 Dec; 56(6):622-623. PubMed ID: 34732909
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of COVID-19 pandemic on the scientific community.
    Subramanya SH; Lama B; Acharya KP
    Qatar Med J; 2020; 2020(1):21. PubMed ID: 32733784
    [No Abstract]   [Full Text] [Related]  

  • 14. Managing an oncology clinic during the COVID-19 pandemic-how we did it in Sarajevo?
    Beslija S
    Memo; 2020; 13(3):255-256. PubMed ID: 32983275
    [No Abstract]   [Full Text] [Related]  

  • 15. [Covid-19: The impact on people affected by cancer, oncology nurses and the wider healthcare community].
    Cruickshank S
    Enferm Clin; 2021; 31(4):201-202. PubMed ID: 38620678
    [No Abstract]   [Full Text] [Related]  

  • 16. A Call for a Radiation Oncology Model Based on New 4R's During the COVID-19 Pandemic.
    Rathod S; Dubey A; Chowdhury A; Bashir B; Koul R
    Adv Radiat Oncol; 2020; 5(4):608-609. PubMed ID: 32363246
    [No Abstract]   [Full Text] [Related]  

  • 17. Covid-19: Shielding may be reintroduced for vulnerable people in highest risk areas.
    Iacobucci G
    BMJ; 2020 Oct; 371():m3969. PubMed ID: 33051178
    [No Abstract]   [Full Text] [Related]  

  • 18. What happens next: Radiation oncology after COVID?
    Chandra RA; Thomas CR
    Clin Transl Radiat Oncol; 2020 Jul; 23():89-90. PubMed ID: 32524037
    [No Abstract]   [Full Text] [Related]  

  • 19. Oncology and COVID-19.
    Bull Acad Natl Med; 2020 Dec; 204(9):e36-e37. PubMed ID: 32836231
    [No Abstract]   [Full Text] [Related]  

  • 20. COVID-19: A Catalyst for Change for UK Clinical Oncology.
    Coles CE; Choudhury A; Hoskin PJ; Jones CM; O'Leary B; Roques TW; Tharmalingam H; Yuille FAP
    Int J Radiat Oncol Biol Phys; 2020 Oct; 108(2):462-465. PubMed ID: 32890533
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.